{"transactions":[{"id":857021,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-07T00:50:33.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 5, 2027, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":1050000,"derivative":{"exercise_price":1.84,"expiration_date":"2036-03-05","underlying":"Common Shares","underlying_shares":1050000},"source":{"system":"sec-edgar","filing":"0001193125-26-097184","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000119312526097184/ownership.xml","form_type":"4"}},{"id":1210865,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-12T21:30:36.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 10, 2026, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":750000,"derivative":{"exercise_price":0.53,"expiration_date":"2035-03-10","underlying":"Common Shares","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0000950170-25-038116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017025038116/ownership.xml","form_type":"4"}},{"id":1351684,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-11-26T21:58:31.000Z","date":"2024-11-26","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.59,"value":8850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5925 to $0.5929, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1."}],"balance_after":25500,"source":{"system":"sec-edgar","filing":"0000950170-24-131098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017024131098/ownership.xml","form_type":"4"}},{"id":1430207,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-08-19T22:24:46.000Z","date":"2024-08-16","kind":"purchase","planned":false,"acquired":true,"shares":10500,"price":0.89,"value":9345.0,"ownership":{"direct":true},"balance_after":10500,"source":{"system":"sec-edgar","filing":"0000950170-24-098731","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017024098731/ownership.xml","form_type":"4"}},{"id":1488067,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T16:33:47.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 12,500 shares of the Issuer's common stock, and vests in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":12500,"derivative":{"exercise_price":0.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-24-069928","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017024069928/ownership.xml","form_type":"4"}},{"id":1488066,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T16:33:47.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 12,500 restricted stock units, which vest in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":31916,"source":{"system":"sec-edgar","filing":"0000950170-24-069928","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017024069928/ownership.xml","form_type":"4"}},{"id":1587954,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-08T21:05:26.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 7, 2025, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":650000,"derivative":{"exercise_price":1.13,"expiration_date":"2034-03-07","underlying":"Common Shares","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001493152-24-009379","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315224009379/ownership.xml","form_type":"4"}},{"id":1851412,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:05:53.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 12,500 shares of the Issuer's common stock, and vests in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":12500,"derivative":{"exercise_price":4.7,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-23-028594","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017023028594/ownership.xml","form_type":"4"}},{"id":1851411,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T16:05:53.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 12,500 restricted stock units, which vest in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":19416,"source":{"system":"sec-edgar","filing":"0000950170-23-028594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017023028594/ownership.xml","form_type":"4"}},{"id":1959831,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-11T00:02:18.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 9, 2024, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":150000,"derivative":{"exercise_price":1.46,"expiration_date":"2033-03-09","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-23-007304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223007304/ownership.xml","form_type":"4"}},{"id":2061731,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series X Preferred Stock","published_at":"2023-01-05T16:05:13.000Z","date":"2023-01-03","kind":"disposition_to_issuer","acquired":false,"shares":19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 10, 2022, the Company's board of directors (the \"Board\") declared a dividend of one one-thousandth of a share of Series X Preferred Stock, par value $0.001 per share (the \"Preferred Stock\"), for each outstanding share of common stock to common stockholders of record at 5:00 p.m. Eastern Time on November 21, 2022, in a transaction exempt from Section 16 under Rule 16a-9. The shares of Preferred Stock were distributed on November 21, 2022. As a result, the Reporting Person received the shares of Preferred Stock set forth above. The Preferred Stock was not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 3, 2023, in connection with the Company's reverse stock split for the common stock, the shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation of the Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.001 in cash (rounded to the nearest cent) for each whole share of Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 3, 2023, in connection with the Company's reverse stock split for the common stock, the shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation of the Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.001 in cash (rounded to the nearest cent) for each whole share of Preferred Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924323000957/doc4.xml","form_type":"4"}},{"id":2115275,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-11-16T21:17:31.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to one quarter of the shares subject to the option on November 14, 2023, and the balance will vest in 36 successive substantially equal installments thereafter, subject to the reporting person's continuous employment."}],"balance_after":1000000,"derivative":{"exercise_price":1.36,"expiration_date":"2032-11-14","underlying":"Common Shares","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001493152-22-032631","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222032631/ownership.xml","form_type":"4"}},{"id":2226767,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T16:31:23.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":148810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F2","text":"This option represents the right to purchase 148,810 shares of the Issuer's common stock, which vest in full on the earlier of (1) June 15, 2023 or (2) the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 148,810 shares of the Issuer's common stock, which vest in full on the earlier of (1) June 15, 2023 or (2) the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":148810,"derivative":{"exercise_price":0.64,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":148810},"source":{"system":"sec-edgar","filing":"0000899243-22-023096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322023096/doc4.xml","form_type":"4"}},{"id":2226766,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T16:31:23.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":96154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 96,154 restricted stock units, which vest in full on the earlier of (1) June 15, 2023 or (2) the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":172908,"source":{"system":"sec-edgar","filing":"0000899243-22-023096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322023096/doc4.xml","form_type":"4"}},{"id":2522506,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T16:35:22.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":82879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F2","text":"This option represents the right to purchase 82,879 shares of the Issuer's common stock, which vest in equal installments on the first, second, third and fourth anniversaries of November 3, 2021, subject to the Reporting Person's continued service to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 82,879 shares of the Issuer's common stock, which vest in equal installments on the first, second, third and fourth anniversaries of November 3, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":82879,"derivative":{"exercise_price":3.11,"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":82879},"source":{"system":"sec-edgar","filing":"0000899243-21-043301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321043301/doc4.xml","form_type":"4"}},{"id":2522505,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":62400,"kind":"person","name":"Howe Jill Ann","position":1,"cik":"0001892397","reported_name":"Howe Jill Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-05T16:35:22.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":76754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 76,754 restricted stock units, which vest in equal installments on the first, second, third and fourth anniversaries of November 3, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":76754,"source":{"system":"sec-edgar","filing":"0000899243-21-043301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321043301/doc4.xml","form_type":"4"}}]}